Abstract: Disclosed herein is a topical treatment regimen including a prostaglandin F2? analog and a topical steroid for treating skin conditions, including skin pigmentation disorders associated with hypopigmentation such as vitiligo and nonfacial vitiligo. Examples of prostaglandin F2? analogs include bimatoprost, carboprost, dinoprost, fluprostenol, latanoprost, prostamide F2?, tafluprost, travoprost, and unoprostone, with bimatoprost being preferred. Examples of topical steroids include aclometasone, betamethasone, clobetasol, clobetasone, diflucortolone, fluocinolone, fluprednidene, flurandrenolide, fluticasone, halometasone, hydrocortisone, methylprednisolone, mometasone, prednicarbate, and triamcinolone, with mometasone being preferred. The topical treatment regimen includes one or more topical compositions, with the prostaglandin F2? analog and the topical steroid being contained either in separate topical compositions or in the same topical composition.

Abstract: A microdermabrasion composition is provided. The composition preferably has 2-60 weight percent surfactant, 5-60 weight percent volatile silicone oil, 8-50 weight percent anhydrous solvent, and 1-25 weight percent water soluble salt. The water soluble salt is most preferably sodium chloride. The composition is effective and safe for in-home microdermabrasion. A kit including such a microdermabrasion composition and an applicator sponge, and a method of microdermabrasion are also provided.

Abstract: A microdermabrasion composition is provided. The composition preferably has 2-60 weight percent surfactant, 5-60 weight percent volatile silicone oil, 8-50 weight percent anhydrous solvent, and 1-25 weight percent water soluble salt. The water soluble salt is most preferably sodium chloride. The composition is effective and safe for in-home microdermabrasion. A kit including such a microdermabrasion composition and an applicator sponge, and a method of microdermabrasion are also provided.